Publications by authors named "K Chaba"

Claim this Profile
M
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00.
S Rusakiewicz, S Tyekucheva, S Tissot-Renaud, K Chaba, M Imbimbo

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Analysis of the PRODIGE-GERCOR IDEA-France Trial.
Julien Taieb, Valérie Taly, Julie Henriques, Camille Bourreau, Laurent Mineur, Kariman Chaba

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.
Mario Jreige, Igor Letovanec, Kariman Chaba, Stephanie Renaud, Sylvie Rusakiewicz

Eur J Nucl Med Mol Imaging· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune effectors responsible for the elimination of hyperploid cancer cells.
Fernando Aranda, Kariman Chaba, Norma Bloy, Pauline Garcia, Chloé Bordenave

Oncoimmunology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.
Sylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, Jonathan M Pitt, Elke Pogge von Strandmann, Kariman Chaba

Oncoimmunology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis